4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-18-000104
Options or other derivatives
- CEO acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Jaksch Frank L Jr · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-21 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +50,000 | 50,000 | D |
Loading xslF345X03/form4-01232018_010152.xml…